People
Find researchers
Who has published, run trials or held grants on a topic, and how to reach them through people they have worked with.
Ranked by expertise@1: every paper, trial or grant they worked on in scope counts, recent work counts more, and being first or last author or a trial’s principal investigator counts 1.5 times.
Researchers with CLDN18.2 work
238 researchers in CLDN18.2, best first; 76–100 shown.
- Chen Liu · Fudan University
In CLDN18.2: 1 paper. Expertise score 1.08. 24 papers in all, 2012–2025.
Topics: All pancreatic cancer, KRAS, KRAS G12D, CLDN18.2
- Jianjun Liu
In CLDN18.2: 1 trial. Expertise score 1.08. 1 paper, 1 trial in all, 2023–2024.
Topics: All pancreatic cancer, CLDN18.2
- Li Yu
In CLDN18.2: 1 paper. Expertise score 1.08. 1 paper in all, 2024.
Topics: CLDN18.2, All pancreatic cancer
- Xinglu Huang
In CLDN18.2: 1 paper. Expertise score 1.08. 1 paper in all, 2024.
Topics: CLDN18.2, All pancreatic cancer
- Xuan Lin
In CLDN18.2: 1 paper. Expertise score 1.08. 19 papers in all, 2020–2026.
Topics: All pancreatic cancer, CLDN18.2, Early detection, KRAS, KRAS G12D
- Yan Leyfman · Icahn School of Medicine at Mount Sinai
In CLDN18.2: 1 paper. Expertise score 1.08. 2 papers in all, 2024.
Topics: All pancreatic cancer, CLDN18.2, Early detection
- Yingjie Jia · First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
In CLDN18.2: 1 paper. Expertise score 1.08. 1 paper in all, 2024.
Topics: CLDN18.2, All pancreatic cancer
- Feifan Yu · Alphathera, Inc.
In CLDN18.2: 1 grant. Expertise score 1.04. 1 grant in all, 2022.
Topics: CLDN18.2, All pancreatic cancer
- Aldo Scarpa · University of Verona
In CLDN18.2: 1 paper. Expertise score 1.00. 130 papers in all, 2011–2026.
Topics: All pancreatic cancer, KRAS, Early detection, CLDN18.2
- Allison L. Kerper · Mayo Clinic
In CLDN18.2: 1 paper. Expertise score 1.00. 1 paper in all, 2026.
Topics: CLDN18.2, All pancreatic cancer
- Baiyong Shen · Shanghai Jiao Tong University
In CLDN18.2: 1 paper. Expertise score 1.00. 95 papers in all, 2012–2026.
Topics: All pancreatic cancer, KRAS, Early detection, KRAS G12D, CLDN18.2
- Berina Šabanović
In CLDN18.2: 1 paper. Expertise score 1.00. 10 papers in all, 2019–2026.
Topics: All pancreatic cancer, KRAS, CLDN18.2, Early detection, KRAS G12D
- Carlotta Franzina · University of Verona
In CLDN18.2: 1 paper. Expertise score 1.00. 3 papers in all, 2025–2026.
Topics: All pancreatic cancer, CLDN18.2, KRAS
- Chao Wu
In CLDN18.2: 1 paper. Expertise score 1.00. 9 papers in all, 2020–2026.
Topics: All pancreatic cancer, KRAS, CLDN18.2
- Chao Yang
In CLDN18.2: 1 paper. Expertise score 1.00. 6 papers in all, 2025–2026.
Topics: All pancreatic cancer, KRAS, CLDN18.2
- Chenlei Wen
In CLDN18.2: 1 paper. Expertise score 1.00. 27 papers in all, 2016–2026.
Topics: All pancreatic cancer, KRAS, KRAS G12D, CLDN18.2
- Daisuke Kyuno · Sapporo Medical University
In CLDN18.2: 1 paper. Expertise score 1.00. 13 papers in all, 2011–2026.
Topics: All pancreatic cancer, CLDN18.2
- Ebru Karcı · Atlas Üniversitesi
In CLDN18.2: 1 paper. Expertise score 1.00. 1 paper in all, 2026.
Topics: CLDN18.2, All pancreatic cancer
- Francisco Cézar Aquino de Moraes · Universidade Federal do Pará
In CLDN18.2: 1 paper. Expertise score 1.00. 2 papers in all, 2025–2026.
Topics: All pancreatic cancer, CLDN18.2
- Gin Wai Kwok
In CLDN18.2: 1 paper. Expertise score 1.00. 1 paper in all, 2026.
Topics: CLDN18.2, KRAS, All pancreatic cancer
- Giuseppe Malleo
In CLDN18.2: 1 paper. Expertise score 1.00. 102 papers, 1 trial in all, 2011–2026.
Topics: All pancreatic cancer, KRAS, Early detection, CLDN18.2
- Güner Akgüner · Ankara Etlik City Hospital
In CLDN18.2: 1 paper. Expertise score 1.00. 1 paper in all, 2026.
Topics: CLDN18.2, All pancreatic cancer
- Hang Yin · Jining Medical University
In CLDN18.2: 1 paper. Expertise score 1.00. 1 paper in all, 2026.
Topics: CLDN18.2, All pancreatic cancer
- Hirohisa Okabe
In CLDN18.2: 1 paper. Expertise score 1.00. 24 papers in all, 2015–2026.
Topics: All pancreatic cancer, CLDN18.2, KRAS
- Hiroki Tsubakihara · Kumamoto University
In CLDN18.2: 1 paper. Expertise score 1.00. 1 paper in all, 2026.
Topics: CLDN18.2, All pancreatic cancer